Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$181.70
4.472.52%
Last update: Oct 2, 5:57 PM
$181.70
4.472.52%
Repligen Corp (RGEN) Stock Price, Quote, News & History
RGENNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Other companies in Repligen’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Illumina Inc (NASDAQ:ILMN).
Repligen has a consensus price target of $174.52.
The stock price for Repligen (NASDAQ: RGEN) is $181.7 last updated October 2, 2026 at 5:57 PM EDT.
There are no upcoming dividends for Repligen.
Repligen does not have any upcoming earnings scheduled.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
